rowasip cold and flu with decongestant 500 mg/12.2 mg powder for oral solution
rowex ltd - paracetamol; phenylephrine hydrochloride - powder for oral solution - 500 mg/12.2 milligram(s) - anilides; paracetamol, combinations excl. psycholeptics
rowasip max strength cold and flu with decongestant 1000 mg/12.2 mg powder for oral solution
rowex ltd - phenylephrine hydrochloride; paracetamol - powder for oral solution - 1000 mg/12.2 milligram(s) - anilides; paracetamol, combinations excl. psycholeptics
coccibal oral solution for poultry 200 mg /ml
sp veterinaria s.a - amprolium chlorohydrate 200 mg/ml - oral solution - chicken, turkeys - amprolium
coccibal oral solution for poultry 200 mg /ml
sp veterinaria s.a - amprolium chlorohydrate 200 mg/ml - oral solution - chicken, turkeys - amprolium
coccibal oral solution for poultry 200 mg /ml
sp veterinaria s.a - amprolium chlorohydrate 200 mg/ml - oral solution - chicken, turkeys - amprolium
coccibal oral solution for poultry 200 mg /ml
sp veterinaria s.a - amprolium chlorohydrate 200 mg/ml - oral solution - chicken, turkeys - amprolium
coccibal oral solution for poultry 200 mg /ml
sp veterinaria s.a - amprolium chlorohydrate 200 mg/ml - oral solution - chicken, turkeys - amprolium
coccibal oral solution for poultry 200 mg /ml
sp veterinaria s.a - amprolium chlorohydrate 200 mg/ml - oral solution - chicken, turkeys - amprolium
valproic acid- valproic acid solution
par pharmaceutical - valproic acid (unii: 614oi1z5wi) (valproic acid - unii:614oi1z5wi) - valproic acid 250 mg in 5 ml - valproic acid oral solution is indicated as monotherapy and adjunctive therapy in the treatment of patients with complex partial seizures that occur either in isolation or in association with other types of seizures. valproic acid oral solution is indicated for use as sole and adjunctive therapy in the treatment of simple and complex absence seizures, and adjunctively in patients with multiple seizure types which include absence seizures. simple absence is defined as very brief clouding of the sensorium or loss of consciousness accompanied by certain generalized epileptic discharges without other detectable clinical signs. complex absence is the term used when other signs are also present. see warnings and precautions (5.1) for statement regarding fatal hepatic dysfunction. because of the risk to the fetus of decreased iq, neural tube defects, and other major congenital malformations, which may occur very early in pregnancy, valproate should not be administered to a woman of childbearing potential unless th
valproic acid- valproic acid solution
cardinal health - valproic acid (unii: 614oi1z5wi) (valproic acid - unii:614oi1z5wi) - valproic acid 250 mg in 5 ml - valproic acid is indicated as monotherapy and adjunctive therapy in the treatment of patients with complex partial seizures that occur either in isolation or in association with other types of seizures. valproic acid is indicated for use as sole and adjunctive therapy in the treatment of simple and complex absence seizures, and adjunctively in patients with multiple seizure types which include absence seizures. simple absence is defined as very brief clouding of the sensorium or loss of consciousness accompanied by certain generalized epileptic discharges without other detectable clinical signs. complex absence is the term used when other signs are also present. see warnings and precaution (5.1) for statement regarding fatal hepatic dysfunction. because of the risk to the fetus of decreased iq, neural tube defects, and other major congenital malformations, which may occur very early in pregnancy, valproate should not be administered to a woman of childbearing potential unless the drug is essential to the man